Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Other Non-Current Liabilities (2024 - 2025)

Historic Other Non-Current Liabilities for Krystal Biotech (KRYS) over the last 2 years, with Q3 2025 value amounting to $3.1 million.

  • Krystal Biotech's Other Non-Current Liabilities rose 31222.08% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 31222.08%. This contributed to the annual value of $1.4 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Krystal Biotech reported Other Non-Current Liabilities of $3.1 million as of Q3 2025, which was up 31222.08% from $2.8 million recorded in Q2 2025.
  • Krystal Biotech's 5-year Other Non-Current Liabilities high stood at $3.1 million for Q3 2025, and its period low was $588000.0 during Q2 2024.